The report on vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the Global Vaccine Market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global vaccine market over the period of 2015 - 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.
The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include:
- Company reports and publications
- Government/institutional publications
- Trade and associations’ journals
- Databases such as WTO, OECD, World Bank, and among others.
- Websites and publications by research agencies
The Global Vaccine Market is segmented on the basis of Type, and Application.
Global Vaccine Market by Type
- DNA vaccines
- Conjugate vaccines
- Live attenuated vaccines
- Inactivated vaccines
- Toxoid vaccines
- Subunit vaccines
- Infectious Diseases
- North America
- Mitsubishi Tanabe
- Merck & Co. Inc
- GlaxoSmithKline plc (GSK)
- Pfizer Inc.
- SANOFI S.A
- NOVARTIS AG
- Takeda Pharmaceuticals
- Astellas Pharma Inc.
- Emergent BioSolutions
1. Comprehensive analysis of global as well as regional markets of Vaccine Market.
2. Complete coverage of all the segments in Vaccine Market to analyze the trends, developments in the Global Market and forecast of market size up to 2023.
3. Comprehensive analysis of the companies operating in Global Vaccine Market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Vaccine Market Overview
3.2 Market Dynamics
3.3 Porter’s Five Forces Analysis
3.4 Growth Matrix Analysis
3.5 Competitive Landscape in the Global Vaccine Market
4. Global Vaccine Market by Type 2017 - 2023
4.1 DNA vaccines
4.2 Conjugate vaccines
4.3 Live attenuated vaccines
4.4 Inactivated vaccines
4.5 Toxoid vaccines
4.6 Subunit vaccines
5. Global Vaccine Market by Application 2017 - 2023
5.4 Infectious Diseases
6. Global Vaccine Market by Regions 2017 - 2023
6.1 North America
6.1.1 North America Vaccine Market by Type
6.1.2 North America Vaccine Market by Application
6.1.3 North America Vaccine Market by Country
6.2.1 Europe Vaccine Market by Type
6.2.2 Europe Vaccine Market by Application
6.2.3 Europe Vaccine Market by Country
6.3.1 Asia-Pacific Vaccine Market by Type
6.3.2 Asia-Pacific Vaccine Market by Application
6.3.3 Asia-Pacific Vaccine Market by Country
6.4.1 RoW Vaccine Market by Type
6.4.2 RoW Vaccine Market by Application
6.4.3 RoW Vaccine Market by Sub-region
7. Companies Covered
7.1 Mitsubishi Tanabe
7.3 Merck & Co. Inc
7.4 GlaxoSmithKline plc (GSK)
7.5 Pfizer Inc.
7.6 SANOFI S.A
7.7 NOVARTIS AG
7.8 Takeda Pharmaceuticals
7.9 Astellas Pharma Inc.
7.10 Emergent BioSolutions